Adnan Said | Medicine | Best Researcher Award

Best Researcher Award

Adnan Said
University of Wisconsin School of Medicine and Public Health

Adnan Said
Affiliation University of Wisconsin School of Medicine and Public Health
Country United States
Scopus Id 35582909600
Documents 107
Citation 5,510
h-index 35
Subject Area Medicine
Event International Popular Scientist Awards
Orcid 0000-0001-9944-4071

Adnan Said is a medicine researcher affiliated with the University of Wisconsin School of Medicine and Public Health in the United States. The researcher profile supplied for this article lists 107 documents, 5,510 citations, and an h-index of 35 in Scopus, with research activity represented across hepatology, interventional radiology, liver transplantation, portal hypertension, and related clinical and translational areas. The publication record includes collaborative studies addressing transjugular intrahepatic portosystemic shunt (TIPS) procedures, gastrointestinal bleeding, liver fibrosis, and transplantation. [1]

Abstract

This academic recognition profile presents the research record of Adnan Said, whose supplied Scopus profile contains 107 documents, 5,510 citations, and an h-index of 35. His publication contributions represented in the supplied record focus substantially on liver-related clinical research, including portal hypertension, TIPS, gastrointestinal bleeding, liver transplantation, hepatic fibrosis, and associated diagnostic and therapeutic questions. The listed publications also demonstrate collaboration across multidisciplinary research groups involving hepatology, interventional radiology, transplantation, nuclear medicine, and related clinical sciences. [1]

Keywords

Adnan Said; Medicine; Hepatology; Liver Disease; Portal Hypertension; TIPS; Liver Transplantation; Gastrointestinal Bleeding; Liver Fibrosis; Interventional Radiology; Clinical Research; Translational Medicine; Research Impact.

Introduction

Research in hepatology and liver medicine encompasses complex interactions between chronic liver disease, portal hypertension, transplantation, vascular interventions, and complications such as gastrointestinal bleeding. Contemporary clinical investigation in these areas frequently combines patient outcomes, procedural variables, diagnostic imaging, and translational approaches. The publications supplied for this profile place Adnan Said within this multidisciplinary research environment, with several studies examining outcomes associated with TIPS and liver transplantation. [2]

Research Profile

The supplied bibliometric information identifies Adnan Said as a medicine researcher with a Scopus author identifier of 35582909600. The stated profile includes 107 documents, 5,510 citations, and an h-index of 35. These indicators describe the publication and citation record supplied for this recognition page and should be interpreted in the context of the coverage, indexing practices, author-disambiguation procedures, and update timing of the relevant database. [1]

The supplied publications demonstrate substantial collaborative authorship. The listed studies involve investigators from different clinical and research specialties and include multi-author ALTA Group investigations. Such collaboration is particularly relevant to complex liver-care research, where procedural outcomes, patient characteristics, imaging, transplantation, and clinical management may require integrated expertise.

Research Contributions

The supplied publications identify several recurring research themes. One area concerns outcomes following TIPS, a procedure used in the management of selected complications of portal hypertension. A 2025 ALTA Group study examined portal hypertensive gastropathy and MELD-Na score in relation to recurrent gastrointestinal bleeding after TIPS. [1]

Another contribution concerns changes in platelet count following TIPS creation. The 2023 study was conducted by the ALTA Group and investigated platelet-count changes after the procedure, contributing to the broader evaluation of physiological and clinical outcomes associated with TIPS. [2]

Publications

The following publications are drawn from the supplied Crossref-indexed publication information and represent selected research contributions associated with Adnan Said.

  1. Portal Hypertensive Gastropathy and MELD-Na Score Predict Recurrent Gastrointestinal Bleeding After TIPSS: An ALTA Group Study. Alimentary Pharmacology & Therapeutics.
  2. Change in Platelet Count after Transjugular Intrahepatic Portosystemic Shunt Creation: An Advancing Liver Therapeutic Approaches (ALTA) Group Study. Journal of Vascular and Interventional Radiology.
  3. The impact of right atrial pressure on outcomes in patients undergoing TIPS, an ALTA group study. Hepatology.
  4. Staging Liver Fibrosis by Fibroblast Activation Protein Inhibitor Positron Emission Tomography in a Human-sized Swine Model. Journal of Nuclear Medicine.
  5. Utilization of hepatitis C viremic donors for liver transplant recipients without hepatitis C. A veterans transplant center report. Transplant Infectious Disease.

Research Impact

The supplied Scopus metrics of 5,510 citations and an h-index of 35 provide bibliometric measures of the visibility and citation history associated with the identified author profile. [1] Bibliometric indicators are quantitative measures and do not independently establish the clinical effectiveness, methodological quality, or practical significance of individual studies.

Within the supplied publication sample, the research addresses clinically relevant questions concerning TIPS, portal hypertension, gastrointestinal bleeding, hemodynamic factors, liver fibrosis imaging, and transplantation. The combination of clinical studies, collaborative group research, and translational investigation indicates engagement with multiple dimensions of liver medicine. [1] [2] [3] [4] [5]

Award Suitability

For the purposes of the International Popular Scientist Awards, the supplied record provides several documented elements relevant to an academic recognition profile: a substantial indexed publication record, reported citation activity, an h-index of 35, and research contributions in medicine. The selected publications demonstrate work in liver-related clinical and translational research, including TIPS outcomes, portal hypertension, liver fibrosis imaging, and transplantation. [1]–[5]

Conclusion

Adnan Said’s supplied academic profile represents a research portfolio in medicine with notable emphasis on hepatology, liver-related interventions, transplantation, portal hypertension, and translational imaging. The stated Scopus record comprises 107 documents, 5,510 citations, and an h-index of 35. The selected publications further document participation in collaborative investigations addressing TIPS outcomes, gastrointestinal bleeding, platelet changes, hemodynamics, liver fibrosis, and transplantation. [1]–[5]

References

  1. Hu, K.; Sedki, M.; Kwong, A.; Kesselman, A.; Kolli, K. P.; Morelli, G.; Spengler, E.; Said, A.; Lai, J.; Desai, A.; et al. (2025). Portal Hypertensive Gastropathy and MELD-Na Score Predict Recurrent Gastrointestinal Bleeding After TIPSS: An ALTA Group Study. Alimentary Pharmacology & Therapeutics.
    https://doi.org/10.1111/apt.18362
  2. Wong, R. J.; Ge, J.; Boike, J.; German, M.; Morelli, G.; Spengler, E.; Said, A.; Desai, A.; Couri, T.; Paul, S.; et al. (2023). Change in Platelet Count after Transjugular Intrahepatic Portosystemic Shunt Creation: An Advancing Liver Therapeutic Approaches (ALTA) Group Study. Journal of Vascular and Interventional Radiology.
    https://doi.org/10.1016/j.jvir.2023.04.015
  3. Bommena, S.; Mahmud, N.; Boike, J. R.; Thornburg, B. G.; Kolli, K. P.; Lai, J. C.; German, M.; Morelli, G.; Spengler, E.; Said, A.; et al. (2023). The impact of right atrial pressure on outcomes in patients undergoing TIPS, an ALTA group study. Hepatology.
    https://doi.org/10.1097/HEP.0000000000000283
  4. Pirasteh, A.; Periyasamy, S.; Meudt, J. J.; Lui, Y.; Lee, L. M.; Schachtschneider, K. M.; Schook, L. B.; Gaba, R. C.; Mao, L.; Said, A.; et al. (2022). Staging Liver Fibrosis by Fibroblast Activation Protein Inhibitor Positron Emission Tomography in a Human-sized Swine Model. Journal of Nuclear Medicine.
    https://doi.org/10.2967/jnumed.121.263736
  5. Said, A.; Weiss, M.; Varhelyi, A.; Farago, R.; Ballweg, C.; Rice, J.; Agarwal, P.; Fernandez, L.; Foley, D. (2021). Utilization of hepatitis C viremic donors for liver transplant recipients without hepatitis C. A veterans transplant center report. Transplant Infectious Disease.
    https://doi.org/10.1111/tid.13466
  6. Elsevier. (n.d.). Scopus author details: Adnan Said, Author ID 35582909600. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=35582909600

Isaac Egesa | Medicine | Best Researcher Award

Best Researcher Award

Isaac Egesa
University of Liverpool, United Kingdom

Isaac Egesa
Affiliation University of Liverpool
Country United Kingdom
Scopus ID 57354615500
Documents 6
Citations 35
h-index 3
Subject Area Medicine
Event International Popular Scientist Awards
ORCID 0000-0003-0483-1517

Isaac Egesa is a researcher affiliated with the University of Liverpool whose reported scholarly work is situated within medicine and clinical research methodology. His recent publications and research protocols address patient and public involvement and engagement, sequential multiple-assignment randomized trials, target trial emulation, focal epilepsy, evidence synthesis, and methodological standards for clinical research. His Scopus profile records six indexed documents, 35 citations, and an h-index of 3. [1]

Abstract

Isaac Egesa’s recent research record reflects an emerging focus on clinical research methodology and evidence-based medicine. His work includes investigations of patient and public involvement and engagement in sequential multiple-assignment randomized trials and target trial emulation, as well as systematic evidence synthesis concerning antiseizure medication strategies for focal epilepsy. His publications span journal articles, research protocols, and conference outputs published or disseminated between 2025 and 2026. [2] [3] [4]

Keywords

Isaac Egesa; Best Researcher Award; Medicine; Clinical Research; Evidence-Based Medicine; Sequential Multiple-Assignment Randomized Trials; Target Trial Emulation; Patient and Public Involvement; Focal Epilepsy; Systematic Review; Clinical Epidemiology; Research Methodology.

Introduction

Contemporary clinical research increasingly requires methodological approaches capable of addressing complex treatment decisions, longitudinal evidence, patient perspectives, and the limitations of conventional randomized trial designs. Sequential multiple-assignment randomized trials (SMARTs) and target trial emulation are among the approaches used to investigate adaptive treatment strategies and strengthen the design or interpretation of observational and experimental evidence. Egesa’s recent work engages with these methodological areas while also considering the role of patients and the public in the development and conduct of clinical research. [5]

Research Profile

The available research information places Egesa within the medicine and clinical epidemiology research environment at the University of Liverpool. His listed Scopus record contains six documents, 35 citations, and an h-index of 3. [1] The publication record supplied for this profile demonstrates activity across several interconnected methodological themes rather than a single narrowly defined clinical topic.

Research Contributions

A principal component of Egesa’s recent work concerns patient and public involvement and engagement (PPIE). His research examines how PPIE is represented within sequential multiple-assignment randomized trials and target trial emulation frameworks. These studies address methodological questions concerning how patients and members of the public can participate in research processes involving complex trial structures. [2] [4]

Publications

The supplied publication record includes peer-reviewed journal articles, preprints, research protocols, and a conference poster. The following list summarizes the reported works in chronological order from 2025 through 2026.

  1. The extent of Patient and Public Involvement and Engagement in Sequential Multiple Assignment Randomised Trials: a scoping Review. Journal of Clinical Epidemiology, 2026.Contributors include Isaac J. Egesa, Faye D. Baldwin, Molly Wells, Gashirai Mbizvo, Richard Emsley, Laura J. Bonnett, Emily Lam, Andrew Kightley, Anthony G. Marson, and Catrin Tudur Smith.
  2. The extent of Patient and Public Involvement and Engagement in Sequential Multiple Assignment Randomised Trials: a scoping Review. Preprint, 2026. SSRN.
  3. The effectiveness of adding on or switching antiseizure medications after the first fails to control focal epilepsy: A systematic review of randomized controlled trials. Epileptic Disorders, 2026.
  4. Patient and public involvement and engagement in target trial emulation framework: a scoping review protocol. BMJ Open, 2026.

Research Impact

The significance of Egesa’s research can be considered in relation to methodological development in clinical and epidemiological research. His work addresses questions about how complex treatment strategies can be studied, how patient and public perspectives can be incorporated into research frameworks, and how methodological reporting can support interpretation and reproducibility. [2] [5]

Award Suitability

Based on the information supplied for this profile, Egesa’s research record provides a reasonable basis for consideration within a Best Researcher Award category. The record demonstrates recent scholarly activity, peer-reviewed publication, methodological research, protocol development, and participation in collaborative research involving multiple investigators. The available bibliometric indicators also provide measurable evidence of scholarly dissemination through indexed documents and citations. [1]

Conclusion

Isaac Egesa’s recent scholarly output reflects a developing research profile in medicine with a particular emphasis on clinical research methodology, patient and public involvement, adaptive trial designs, target trial emulation, and evidence synthesis. His 2025–2026 publications and protocols demonstrate engagement with contemporary methodological challenges and clinically relevant research questions.

References

  1. Elsevier. (n.d.). Scopus author details: Isaac Egesa, Author ID 57354615500. Scopus.
    https://www.scopus.com/pages/authors/57354615500
  2. Egesa, I. J., Baldwin, F. D., Wells, M., Mbizvo, G., Emsley, R., Bonnett, L. J., Lam, E., Kightley, A., Marson, A. G., & Tudur Smith, C. (2026). The extent of Patient and Public Involvement and Engagement in Sequential Multiple Assignment Randomised Trials: a scoping Review. Journal of Clinical Epidemiology.
    DOI: 10.1016/j.jclinepi.2026.112455
  3. Egesa, I. J., et al. (2026). The extent of Patient and Public Involvement and Engagement in Sequential Multiple Assignment Randomised Trials: a scoping Review. Preprint. SSRN.
    DOI: 10.2139/ssrn.6502250
  4. Egesa, I. J., Baldwin, F. D., Wells, M., Maden, M., Mbizvo, G. K., Marson, A. G., & Tudur-Smith, C. (2026). Patient and public involvement and engagement in target trial emulation framework: a scoping review protocol. BMJ Open.
    DOI: 10.1136/bmjopen-2025-113432
  5. Egesa, I. J., Bonnett, L., Emsley, R., Marson, A., & Smith, C. T. (2026). A review of use of external data and update on reporting standards in Sequential Multiple-Assignment Randomised Trials. Clinical Trials.
    DOI: 10.1177/17407745251385535